GYO18, 2023 Flashcards

1
Q

What is the study question of GYO18?

A

Pembrolizumab vs placebo to the standard chemotherapy backbone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Results of GYO18?

A

At 12 mo for MMRd, PFS 74% vs 38% favoring pembro

13 vs 8.7 mo for MMRp with 46% lower risk of PD or death

G3+ adverse events were higher in the pembro groups

2y GYO18; 3y RUBY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly